Virtu KCG Holdings’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Virtu KCG Holdings’s Portfolio YTEN Stock Details YTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-6	Closed	-$21K	–	3871
2016 Q4	$21K	Buy	+6	New	+$23K	﹤0.01%	3229
2015 Q2	–	Sell	-1	Closed	-$41K	–	3861
2015 Q1	$41K	Buy	+1	New	+$32K	﹤0.01%	2858
2014 Q3	–	Hold	0	–	-$18K	–	4175
2014 Q2	–	Hold	0	–	–	–	3534
2014 Q1	–	Sell	-2	Closed	-$158K	–	3428
2013 Q4	$111K	Buy	+2	New	+$134K	﹤0.01%	3409
2013 Q3	–	Hold	0	–	–	–	3638

Other funds holding YTEN

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu KCG Holdings's YTEN Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q1 2017, closing a stake of 6 shares — an estimated $21K sold.

Virtu KCG Holdings first reported a position in YTEN in Q4 2013 and held it in 3 quarters. The position peaked at $111K in Q4 2013. 10 funds tracked by Wall St. Rank hold YTEN as of Q1 2017.

Virtu KCG Holdings reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
Virtu KCG Holdings sold 6 Yield10 Bioscience, Inc. Common Stock shares in Q1 2017, an estimated $21K.
Virtu KCG Holdings first reported a position in Yield10 Bioscience, Inc. Common Stock in Q4 2013 and held it in 3 quarters.
Virtu KCG Holdings's Yield10 Bioscience, Inc. Common Stock position peaked at $111K in Q4 2013.
10 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.